Abstract
Transient neurologic syndrome (TNS) is a common self-limited complication of spinal anesthesia. Many local anesthetics can cause transient neurological syndrome, in which the incidence of lidocaine is relatively high. In addition, bupivacaine, levobupivacaine, articaine, and ropivacaine can also cause TNS. We conducted a consecutive retrospective cohort study to investigate the incidence of TNS and its associated factors in patients treated with bupivacaine and ropivacaine. We conducted a retrospective cohort study, reviewing the medical records of surgical patients who received bupivacaine and ropivacaine spinal anesthesia in Chengdu Shuangliu District First People’s Hospital in the past year to determine the incidence of TNS. For the first time, we used the TNS score table to quantify the occurrence of TNS. There were 24 cases (41.38%) of TNS in the bupivacaine group and 45 cases (33.33%) of TNS in the ropivacaine group. There was no significant difference in VAS and TNS scores between the two groups. It was found that the occurrence of TNS with bupivacaine was correlated with VAS score (Pearson correlation = 0.1813), while the occurrence of TNS with ropivacaine was correlated with sensory blockade (Pearson correlation = − 0.0642). The TNS scale can be used to evaluate the postoperative TNS of patients, and ropivacaine is used for spinal anesthesia with appropriate high anesthesia, which is less likely to lead to postoperative TNS.
Similar content being viewed by others
References
Harned ME, Dority J, Hatton KW. Transient neurologic syndrome: a benign but confusing clinical problem. Adv Emerg Nurs J. 2011;33(3):232–6.
Zaric D, Pace NL. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev. 2009;2:CD003006.
Sankar A, Behboudi M, Abdallah FW, Macfarlane A, Brull R. Transient neurologic symptoms following spinal anesthesia with isobaric mepivacaine: a decade of experience at Toronto Western Hospital. Anesthesiol Res Pract. 2018;2018:1901426.
Etezadi F, Karimi Yarandi K, Ahangary A, Shokri H, Imani F, Safari S, et al. The effect of needle type, duration of surgery and position of the patient on the risk of transient neurologic symptoms. Anesth Pain Med. 2013;2(4):154–8.
Horlocker TT, Wedel DJ. Neurologic complications of spinal and epidural anesthesia. Reg Anesth Pain Med. 2000;25(1):83–98.
Keld DB, Hein L, Dalgaard M, Krogh L, Rodt SA. The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand. 2000;44(3):285–90.
Blanie A, Figueiredo S, Lorre G, Benhamou D. Transient neurologic symptoms (TNS) after intrathecal injection of ropivacaine through a dural tap during an attempted epidural for labour pain relief. Anaesth Crit Care Pain Med. 2017;36(5):325–26.
Gautier PE, De Kock M, Van Steenberge A, Poth N, Lahaye-Goffart B, Fanard L, et al. Intrathecal ropivacaine for ambulatory surgery. Anesthesiology. 1999;91(5):1239–45.
Ganapathy S, Sandhu HB, Stockall CA, Hurley D. Transient neurologic symptom (TNS) following intrathecal ropivacaine. Anesthesiology. 2000;93(6):1537–9.
Takenami T, Wang G, Nara Y, Fukushima S, Yagishita S, Hiruma H, et al. Intrathecally administered ropivacaine is less neurotoxic than procaine, bupivacaine, and levobupivacaine in a rat spinal model. Can J Anaesth. 2012;59(5):456–65.
Wulf H, Hampl K, Steinfeldt T. Speed spinal anesthesia revisited: new drugs and their clinical effects. Curr Opin Anaesthesiol. 2013;26(5):613–20.
Vaghadia H, Neilson G, Lennox PH. Selective spinal anesthesia for outpatient transurethral prostatectomy (TURP): randomized controlled comparison of chloroprocaine with lidocaine. Acta Anaesthesiol Scand. 2012;56(2):217–23.
Wu CL, Berenholtz SM, Pronovost PJ, Fleisher LA. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology. 2002;96(4):994–1003.
Lirk P, Haller I, Colvin HP, Lang L, Tomaselli B, Klimaschewski L, et al. In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Anesth Analg. 2008;106(5):1456–64.
YaDeau JT, Liguori GA, Zayas VM. The incidence of transient neurologic symptoms after spinal anesthesia with mepivacaine. Anesth Analg. 2005;101(3):661–5.
Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med. 2002;27(6):581–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the ethics committee of The First People’s Hospital of Shuangliu District, Chengdu. All study subjects gave informed consent prior to participating in the study.
Conflict of Interest
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Rights and permissions
About this article
Cite this article
Hu, Y., Ye, Y., Gong, X. et al. Transient Neurologic Symptoms Following Spinal Anesthesia with Bupivacaine and Ropivacaine. SN Compr. Clin. Med. 1, 692–697 (2019). https://doi.org/10.1007/s42399-019-00088-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-019-00088-z